Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
232.1 USD | +1.34% | -0.20% | -1.82% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.82% | 11.76B | |
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
+8.35% | 11B | |
-16.39% | 10.07B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Morgan Stanley Adjusts Price Target on Charles River Laboratories International to $230 From $241, Maintains Equal-Weight Rating